PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

Infratil_April_2018_22_25022 - Infratil | Presentation Nation

HomepageInfratilInfratil_April_2018_22_25022

Infratil_April_2018_22_25022

Infratil

Browse presentations, reports, and documents from Infratil.

Tags

2018

Filter options

All (10)●
annual_report (1)○
earnings (1)○
earnings_deck (1)○
investor_presentation (2)○
presentation (5)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

presentation

Format: PDF presentation

Share:

Infratil_April_2018_22_25022 by Infratil.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Infratil

431367-418814

annual_report

a17ace1b-0094-11ec-8963-06ef51a09471

presentation

Similar presentations from other companies

FELE-1Q-2023-Investor-Deck

presentation

Franklin Electric Co

Energy Fuels__2023__418_92418

presentation

Energy Fuels Inc

Genco Shipping & Trading_February_2022_266_79266

CDC investor presentation and guidance update

investor_presentation

investor_presentation

Infratil 2024 NZ$1.15B Equity Raise Investor Presentation

investor_presentation

investor_presentation

40 Pages

Infratil Full Year Results 2021 Investor Presentation

earnings

15 Pages

Infratil FY26 Results announcement date

earnings_deck

presentation

Genco Shipping & Trading

ESNT-Investor-Presentation-1Q23

presentation

Essent Group Limited

FedNat Holding Company_March_2019_167_40167

presentation

Federated National Holding Co

Corporate-Presentation_NOV21

presentation

Silence Therapeutics